Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arlene M Gallagher

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Pharmacoepidemiology and Drug Safety|December 15, 2012
Cancer recording and mortality in the General Practice Research Database and linked cancer registriesRachael Boggon, Tjeerd P van Staa, Michael Chapman, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 26, 2012
Quality of INR control and outcomes following venous thromboembolismArlene M Gallagher, Frank de Vries, Jonathan M Plumb, et al.
BMJ Open|May 28, 2018
Cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data: a cohort studyRachael Williams, Tjeerd-Pieter van Staa, Arlene M Gallagher, et al.
BMJ Open|January 29, 2014
Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomesArlene M Gallagher, Tjeerd P van Staa, Tarita Murray-Thomas, et al.
Calcified Tissue International|April 11, 2012
Risk of fracture with thiazolidinediones: disease or drugs?Marloes T Bazelier, Peter Vestergaard, Arlene M Gallagher, et al.
Pharmacoepidemiology and Drug Safety|March 7, 2012
Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?Marloes T Bazelier, Arlene M Gallagher, Tjeerd-Pieter van Staa, et al.
Pharmacoepidemiology and Drug Safety|July 29, 2016
Comparability of the age and sex distribution of the UK Clinical Practice Research Datalink and the total Dutch populationRoy G P J de Jong, Arlene M Gallagher, Emily Herrett, et al.
Frontiers in Endocrinology|April 4, 2013
Risk of fracture with thiazolidinediones: an individual patient data meta-analysisMarloes T Bazelier, Frank de Vries, Peter Vestergaard, et al.
Pharmacoepidemiology and Drug Safety|April 18, 2019
Limitations for health research with restricted data collection from UK primary careHelen Strongman, Rachael Williams, Wilhelmine Meeraus, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 3, 2019
Quality improvement of prescribing safety: a pilot study in primary care using UK electronic health recordsHelen P Booth, Arlene M Gallagher, David Mullett, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Pharmacoepidemiology and Drug Safety|December 15, 2012
Cancer recording and mortality in the General Practice Research Database and linked cancer registriesRachael Boggon, Tjeerd P van Staa, Michael Chapman, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 26, 2012
Quality of INR control and outcomes following venous thromboembolismArlene M Gallagher, Frank de Vries, Jonathan M Plumb, et al.
BMJ Open|May 28, 2018
Cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data: a cohort studyRachael Williams, Tjeerd-Pieter van Staa, Arlene M Gallagher, et al.
BMJ Open|January 29, 2014
Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomesArlene M Gallagher, Tjeerd P van Staa, Tarita Murray-Thomas, et al.
Calcified Tissue International|April 11, 2012
Risk of fracture with thiazolidinediones: disease or drugs?Marloes T Bazelier, Peter Vestergaard, Arlene M Gallagher, et al.
Pharmacoepidemiology and Drug Safety|March 7, 2012
Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?Marloes T Bazelier, Arlene M Gallagher, Tjeerd-Pieter van Staa, et al.
Pharmacoepidemiology and Drug Safety|July 29, 2016
Comparability of the age and sex distribution of the UK Clinical Practice Research Datalink and the total Dutch populationRoy G P J de Jong, Arlene M Gallagher, Emily Herrett, et al.
Frontiers in Endocrinology|April 4, 2013
Risk of fracture with thiazolidinediones: an individual patient data meta-analysisMarloes T Bazelier, Frank de Vries, Peter Vestergaard, et al.
Pharmacoepidemiology and Drug Safety|April 18, 2019
Limitations for health research with restricted data collection from UK primary careHelen Strongman, Rachael Williams, Wilhelmine Meeraus, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 3, 2019
Quality improvement of prescribing safety: a pilot study in primary care using UK electronic health recordsHelen P Booth, Arlene M Gallagher, David Mullett, et al.
Pageof 3